3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Breast
3
Genitourinary
2
Plasma cell
1
Other hematologic neoplasm
1
Head & Neck
1
CNS
1
Conditions
Head and Neck Neoplasms
408
Squamous Cell Carcinoma of Head and Neck
326
Thyroid Neoplasms
104
Carcinoma, Non-Small-Cell Lung
85
Neoplasms
66
Oropharyngeal Neoplasms
59
Carcinoma, Squamous Cell
59
Melanoma
56
Lung Neoplasms
47
Neoplasm Metastasis
44
Mouth Neoplasms
43
Breast Neoplasms
42
Laryngeal Neoplasms
39
Thyroid Cancer, Papillary
36
Salivary Gland Neoplasms
35
Colorectal Neoplasms
35
Ovarian Neoplasms
33
Carcinoma, Renal Cell
33
Esophageal Neoplasms
32
Urinary Bladder Neoplasms
30
Stomach Neoplasms
30
Tongue Neoplasms
28
Nasopharyngeal Neoplasms
28
Uterine Cervical Neoplasms
27
Carcinoma
27
Pancreatic Neoplasms
26
Triple Negative Breast Neoplasms
24
Sarcoma
24
Carcinoma, Medullary
24
Recurrence
22
Interventions
etelcalcetide hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Bone Diseases
×
Head & Neck
×
Clear all
NCT03960437
2023-09-21
Parsabiv-MBD
Columbia University
Phase 2
Completed
22 enrolled
14 charts